GitLab’s Return on Invested Capital Insights
According to Benzinga Pro data, during Q1, GitLab (NASDAQ:GTLB) posted sales of $87.41 million. Earnings were up 43.09%, but GitLab still reported an overall loss of $26.61 million.
Scotiabank Initiates Coverage On GitLab with Sector Outperform Rating, Announces Price Target of $62
Scotiabank analyst Nick Altmann initiates coverage on GitLab (NASDAQ:GTLB) with a Sector Outperform rating and announces Price Target of $62.
79 Biggest Movers From Yesterday
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.
38 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies.
Why Gitlab Shares Are Rising Today
Gitlab Inc (NASDAQ: GTLB) shares are trading higher by 21.7% at $48.50 after the company reported better-than-expected first-quarter adjusted EPS and sales results and issued second-quarter adjusted EPS and sales guidance above estimates.
UBS Maintains Buy on GitLab, Raises Price Target to $59
UBS analyst Karl Keirstead maintains GitLab (NASDAQ:GTLB) with a Buy and raises the price target from $54 to $59.
Piper Sandler Maintains Overweight on GitLab, Lowers Price Target to $60
Piper Sandler analyst Rob Owens maintains GitLab (NASDAQ:GTLB) with a Overweight and lowers the price target from $75 to $60.
